Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Revenue projections:

Revenue projections for WST
Revenue projections for WST

With WST's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 2.82200
forwardPE 34.78157
debtToEquity 10.58500
earningsGrowth 0.18100
revenueGrowth 0.13800
grossMargins 0.36786
operatingMargins 0.22469
trailingEps 7.80000
forwardEps 9.96476

West Pharmaceutical Services, Inc.'s current ratio of 2.822 means the company has enough liquidity to meet its short-term debt obligations. With sufficient cash reserves and current assets, West Pharmaceutical Services, Inc. can comfortably cover its liabilities, reflecting a strong financial outlook.
West Pharmaceutical Services, Inc.'s low Debt-to-Equity ratio shows that the company avoids excessive reliance on debt, reducing financial risk. This suggests a more secure financial position with less vulnerability to debt-related risks, making West Pharmaceutical Services, Inc. a stable and conservative investment.
WST's positive earnings and revenue growth point to business expansion on the horizon. The company is positioned for continued success, with increasing profits and revenue growth highlighting a strong path forward for future growth.
WST's positive gross and operating margins reflect strong profitability and operational efficiency. These metrics indicate the company's ability to control costs while maintaining healthy revenue, contributing to its solid financial performance.
WST's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that WST is likely to outperform its previous year's financial performance.

Price projections:

Price projections for WST
Price projections for WST

The price of West Pharmaceutical Services, Inc. has regularly been close to the lower end of projections, suggesting that it might be struggling to meet market expectations. This trend raises questions about the company's future performance.

Insider Transactions:

Insider Transactions for WST
Insider Transactions for WST


WST experienced 1 sell transactions with market price of 302.20001220703125 per share.No sell transactions were carried out during the period under review.With more buying than selling around West Pharmaceutical Services, Inc.'s current price, investors could be expressing optimism. This trend may suggest that the market expects favorable outcomes for the stock, leading to an increased demand at these levels.

Recommendation changes over time:

Recommendations trend for WST
Recommendations trend for WST


Analysts' buy bias for West Pharmaceutical Services, Inc. signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to West Pharmaceutical Services, Inc., seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.